Labcorp Holdings Inc. vs Johnson & Johnson
LH vs JNJ — side-by-side comparison from reported financials. LH leads 3, JNJ leads 7 of 10 comparable metrics.
Labcorp Holdings Inc.
LH · Healthcare
$311.84-0.75%Solid
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | LH | JNJ |
|---|---|---|
| Price | $311.84 | $261.79 |
| Market cap | $25.3B | $631B |
| Revenue (TTM) | $14.3B | $97.9B |
| Revenue growth | +5.5% | +5.6% |
| Net margin | 7.0% | 21.5% |
| Free cash flow | $1.16B | $22.2B |
| Net cash (debt) | ($4.55B) | ($27.8B) |
| 1-year price return | +12.3% | +37.0% |
| P/E | 25.3 | 29.9 |
| P/E vs own history (cheap-side %) | 51% | 16% |
| Dividend yield | 0.94% | 2.00% |
| Return on equity | 12% | 26% |
| Altman Z-score | 2.86 | — |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 71,000 | 140,800 |
Full résumé-style profiles: LH CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.